• Mashup Score: 0

    August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in early August by Prof. Dr. Jan De Pooter at the University Hospital Ghent in Belgium. The patient who received an Amvia Sky dual chamber pacemaker device was a 68-year-old man suffering from paroxysmal AV-block strongly limiting his physical efforts.  “The implantation went on straightforward and very smoothly,” commented Prof. De Pooter after the procedure. “LBBAP enables pacing in a very natural, physiological way, benefiting the patient by offering physiological pacing and minimizing the risk for pacing-induced cardiomyopathy.”  The University Hospital Ghent is the first clinic in Europe to implant an Amvia family system. As the first device certified for left bundle branch area pacing (LBBAP)1, Amvia fosters natural myocardial contraction patterns, designed to help reduce the risk of patients developing pacing-induced cardiomyopathy and its severe consequences. It is a

    Tweet Tweets with this article
    • @DAICeditor @BIOTRONIK_US #Biotronik Announces the Full Market Release of Its Newest Family of #Pacemaker and #CRT_P Devices, With #PatientCentric Technologies for Better #PatientCare and Workflow Simplification: https://t.co/VcXIVknCXN

  • Mashup Score: 0

    July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronization therapy pacemaker (CRT-P), its latest innovation in cardiac rhythm management. Amvia Edge, the market’s smallest single-chamber MR conditional pacemaker1, introduces a unique set of patient-centric clinical solutions coupled with automated…

    Tweet Tweets with this article
    • @DAICeditor @BIOTRONIK_US The #AmviaEdge #pacemaker platform introduces always-on, automatic #MR detection algorithm to fully streamline #MRI #workflow: https://t.co/FqVHEdBsxl #FDA #pacemaker

  • Mashup Score: 0

    July 5, 2023 — Research presented during the American Society of Echocardiography’s 34th Annual Scientific Sessions, ASE 2023, June 23-26, 2023, in National Harbor, Md., shared how advances in echocardiography resulted in more accurately placed pacemaker devices. The study, titled 3D Echocardiography Guidance for Pacemaker Lead Placement Improves Accuracy of Lead Placement and Reduces QRS…

    Tweet Tweets with this article
    • @DAICeditor @ChildrensColo @ASE360 Promising new #research #study conducted by Children’s Hospital Colorado found that three-dimensional (3D) #echocardiography resulted in more accurate #pacemaker lead placement when compared to #Xray technology: https://t.co/BaCJwe1otF #ase2023

  • Mashup Score: 0

    May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the world’s first dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three prespecified primary endpoints for safety and performance. The data further suggests that AVEIR DR could offer new benefits for…

    Tweet Tweets with this article
    • @DAICeditor @AbbottCardio Abbott's #AVEIR DR i2i IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber #leadless #pacemaker: https://t.co/iqHX5lv4Ef #HRS23

  • Mashup Score: 0

    May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads. The novel WiSE CRT system removes the possibility of lead complications and provides physicians with more freedom to target the pacing site within the endocardium of the…

    Tweet Tweets with this article
    • @DAICeditor Results from a pivotal clinical trial found a #leadless #pacemaker can deliver #cardiac #resynchronization therapy (#CRT) among patients who were not able to be treated with conventional CRT and #epicardial leads: https://t.co/MEi8YZvONP #HRS23